T2 Biosystems (0A57) Financial Statements
T2 Biosystems Financial Overview
T2 Biosystems's market cap is currently $19.63K. The company's EPS TTM is $-5.95; its P/E ratio is 0.00; T2 Biosystems has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 7.19M | $ 22.30M | $ 28.06M | $ 18.13M | $ 8.34M |
| Gross Profit | $ -8.17M | $ 1.17M | $ 7.36M | $ -3.15M | $ -8.43M |
| Operating Income | $ -49.66M | $ -54.05M | $ -42.97M | $ -41.36M | $ -52.06M |
| EBITDA | $ -43.88M | $ -54.87M | $ -41.13M | $ -36.71M | $ -48.30M |
| Net Income | $ -50.08M | $ -62.00M | $ -49.24M | $ -46.80M | $ -59.01M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 15.69M | $ 10.33M | $ 32.24M | $ 42.19M | $ 11.03M |
| Total Assets | $ 34.80M | $ 34.39M | $ 60.54M | $ 79.08M | $ 28.49M |
| Total Debt | $ 49.50M | $ 59.22M | $ 58.32M | $ 56.92M | $ 44.77M |
| Net Debt | $ 33.81M | $ 48.89M | $ 36.08M | $ 40.13M | $ 33.74M |
| Total Liabilities | $ 62.83M | $ 74.36M | $ 73.44M | $ 70.35M | $ 62.49M |
| Stockholders' Equity | $ -28.04M | $ -39.97M | $ -12.90M | $ 8.73M | $ -34.01M |
| Cash Flow | |||||
| Free Cash Flow | $ -48.33M | $ -50.97M | $ -39.33M | $ -44.02M | $ -46.12M |
| Operating Cash Flow | $ -48.14M | $ -50.63M | $ -38.87M | $ -43.22M | $ -45.36M |
| Investing Cash Flow | $ -192.00K | $ 9.66M | $ 24.79M | $ -36.26M | $ -761.00K |
| Financing Cash Flow | $ 52.69M | $ 29.05M | $ 20.54M | $ 85.61M | $ 6.35M |
Currency in USD
